MétaCan
Menu
← Back to cohort

Abstract P3-11-18: Prognostic significance of lobular versus ductal histology in HER2-positive breast cancer

2025· article· en· W4411288788 on OpenAlexaboutno aff
Alison Laws, Yue Yang, Yuan Xu, Lisa Barbera, May Lynn Quan

Bibliographic record

VenueClinical Cancer Research · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBreast Cancer Treatment Studies
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineHistologyBreast cancerCancerPathologyOncologyInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background: Lobular HER2-positive (HER2+) breast cancer is a rare entity. As such, oncologic outcomes as compared to HER2+ breast cancer with ductal histology are not well-defined. Methods: We identified all non-metastatic HER2+ breast cancers treated with surgery in the province of Alberta, Canada from 2010-2017. We excluded those who had no exposure to trastuzumab. We compared clinicopathologic characteristics by histologic type, categorized as lobular, mixed ductal/lobular or ductal. We used Kaplan Meier methods and the log-rank test to compare recurrence-free survival (RFS) by histologic type. Multivariable Cox proportional hazards analyses were performed to evaluate the association between histology and RFS, adjusting for age, grade, ER status, pT stage and pN stage. Results: Among 1515 HER2+ breast cancer patients, 74 (4.9%) had lobular or mixed ductal/lobular histology (34 pure lobular and 40 mixed) and 1441 (95.1%) had ductal histology. Patients with lobular/mixed histology were older (median age 58.2 vs. 52.9, p<0.001) and had higher proportions of grade 1-2 disease (52.8% vs. 22.1%, p<0.001), ER-positive disease (95.9% vs. 74.3%, p<0.001) and pT3 disease (21.6% vs. 7.1%, p<0.001). Among 398 (26.3%) patients treated with neoadjuvant chemotherapy, the rate of pathologic complete response was 10.0% for lobular/mixed histology vs. 43.9% for ductal (p=0.04). At median follow-up of 4 years, there were 187 recurrences, 92 deaths with recurrence and 20 deaths without recurrence. 5-year RFS was 94.4% (95%CI: 66.6-99.2%) for lobular histology, 86.1% (95%CI: 66.7-94.6%) for mixed ductal/lobular histology and 87.0% (95%CI: 84.4-89.1%) for ductal histology (p=0.75) (Figure). In both unadjusted and adjusted analyses, neither lobular (adjusted HR 1.05, p=0.93) nor mixed histology (adjusted HR 0.71, p=0.46) were associated with worse RFS as compared to ductal histology. pT2-4 (vs. pT1) disease and pN2-3 (vs. pN0) disease were associated with worse RFS (all p<0.01). Results were unchanged in subgroup analysis restricted to ER-positive disease. Conclusion: While lobular cancers are known to be less sensitive to cytotoxic chemotherapy, our data supports that for HER2+ breast cancer treated with HER2-directed antibody therapy, lobular or mixed ductal/lobular histology is not a poor prognostic factor. Citation Format: Alison Laws, Yue Yang, MDSA MEng, Yuan Xu, Lisa Barbera, May Lynn Quan. Prognostic significance of lobular versus ductal histology in HER2-positive breast cancer [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P3-11-18.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.045
Threshold uncertainty score0.090

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.101
GPT teacher head0.478
Teacher spread0.378 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueClinical Cancer Research→Same topicBreast Cancer Treatment Studies→French-language works237,207→